Company: TEM
Filing Date: 2025-02-24
Form Type: 10-K
Source: 0000950170-25-025603
Chunk: 486

Company: Tempus AI, Inc.
Filing Date: 2025-02-24
Form: 10-K
Item: Item 2
Chunk 486
---
11, 2023.
     
    S-1
     
    333-279558
     
    10.21
     
    May 20, 2024

    10.23†
     
    Master Agreement, by and between the Registrant and Recursion Pharmaceuticals, Inc., dated November 3, 2023.
     
    S-1
     
    333-279558
     
    10.22
     
    May 20, 2024

    10.24†
     
    Amendment to Master Services Agreement, by and between Registrant and AstraZeneca AB, dated October 29, 2022.
     
    S-1
     
    333-279558
     
    10.24
     
    May 20, 2024

    10.25†
     
    Second Amendment to Master Services Agreement, by and between Registrant and AstraZeneca UK Ltd, dated February 21, 2023.
     
    S-1
     
    333-279558
     
    10.25
     
    May 20, 2024

182

    Incorporated by Reference 

    ExhibitNumber
     
    Description of Exhibit
     
    Form 
     
    File No. 
     
    Exhibit 
     
    Filing Date 

    10.26†
     
    Third Amendment to Master Services Agreement, by and between Registrant and AstraZeneca AB, dated December 18, 2023.
     
    S-1
     
    333-279558
     
    10.26
     
    May 20, 2024

    10.27†
     
    Joint Venture Agreement, by and among Softbank Group Corporation, Softbank Group Japan Corporation, the Registrant and Pegasos Corp., dated May 18, 2024.
     
    S-1/A
     
    333-279558
     
    10.27
     
    June 5, 2024

    10.28†
     
    Data License Agreement by and between theRegistrant and Pegasos Corp., dated May 18, 2024.
     
    S-1/A
     
    333-279558
     
    10.28
     
    June 5, 2024

    10.29†
     
    Intellectual Property License Agreement, by and between the Registrant and Pegasos Corp., dated May 18, 2024.
     
    S-1/A
     
    333-279558